ELI LILLY & Co → Ionetix Corp / DE /

Stake: — Shares: — CUSIP: 000000000 Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 10/100

Passive Schedule 13G filer baseline
73 NPORT-P mutual funds holding CUSIP

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-09	Boothe Douglas	director	Award	28,229	$0.98	$28K
2026-04-09	Boothe Douglas	director	Award	25,070	$0.98	$25K

Other Filings by ELI LILLY & Co

Filed	Form	Issuer	Stake	Shares
2026-10-16	SCHEDULE 13D	TRex Bio, Inc.	19.90%	5,480,872	view →
2026-07-30	SCHEDULE 13D	Scribe Therapeutics, Inc.	7.30%	1,388,161	view →
2023-08-14	SC	Sigilon Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →